139 related articles for article (PubMed ID: 25785113)
1. XPC codon 939 polymorphism is associated with susceptibility to DNA damage induced by aflatoxin B1 exposure.
Long XD; Huang HD; Huang XY; Yao JG; Xia Q
Int J Clin Exp Med; 2015; 8(1):1197-204. PubMed ID: 25785113
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population.
Long XD; Ma Y; Zhou YF; Ma AM; Fu GH
Hepatology; 2010 Oct; 52(4):1301-9. PubMed ID: 20658464
[TBL] [Abstract][Full Text] [Related]
3. DNA repair gene XRCC7 polymorphisms (rs#7003908 and rs#10109984) and hepatocellular carcinoma related to AFB1 exposure among Guangxi population, China.
Long XD; Yao JG; Huang YZ; Huang XY; Ban FZ; Yao LM; Fan LD
Hepatol Res; 2011 Nov; 41(11):1085-93. PubMed ID: 21883743
[TBL] [Abstract][Full Text] [Related]
4. The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China.
Long XD; Ma Y; Qu DY; Liu YG; Huang ZQ; Huang YZ; Lin ZH; Wei NB; Zhou SC
Ann Epidemiol; 2008 Jul; 18(7):572-8. PubMed ID: 18504145
[TBL] [Abstract][Full Text] [Related]
5. Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.
Yao JG; Huang XY; Long XD
Int J Clin Exp Pathol; 2014; 7(9):6231-44. PubMed ID: 25337275
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China.
Long XD; Ma Y; Huang HD; Yao JG; Qu DY; Lu YL
Mol Carcinog; 2008 Apr; 47(4):295-300. PubMed ID: 17849423
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
Long XD; Zhao D; Wang C; Huang XY; Yao JG; Ma Y; Wei ZH; Liu M; Zeng LX; Mo XQ; Zhang JJ; Xue F; Zhai B; Xia Q
Epidemiology; 2013 Sep; 24(5):671-81. PubMed ID: 23788213
[TBL] [Abstract][Full Text] [Related]
8. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.
McGlynn KA; Rosvold EA; Lustbader ED; Hu Y; Clapper ML; Zhou T; Wild CP; Xia XL; Baffoe-Bonnie A; Ofori-Adjei D
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2384-7. PubMed ID: 7892276
[TBL] [Abstract][Full Text] [Related]
10. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma.
Long XD; Yao JG; Zeng Z; Ma Y; Huang XY; Wei ZH; Liu M; Zhang JJ; Xue F; Zhai B; Xia Q
Hepatology; 2013 Jul; 58(1):171-81. PubMed ID: 23390017
[TBL] [Abstract][Full Text] [Related]
12. The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China.
Long XD; Ma Y; Wei YP; Deng ZL
Hepatol Res; 2006 Sep; 36(1):48-55. PubMed ID: 16884947
[TBL] [Abstract][Full Text] [Related]
13. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
14. AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249.
Weng MW; Lee HW; Choi B; Wang HT; Hu Y; Mehta M; Desai D; Amin S; Zheng Y; Tang MS
Oncotarget; 2017 Mar; 8(11):18213-18226. PubMed ID: 28212554
[TBL] [Abstract][Full Text] [Related]
15. Immunological detection of aflatoxin B1-DNA adducts formed in vivo.
Hsieh LL; Hsu SW; Chen DS; Santella RM
Cancer Res; 1988 Nov; 48(22):6328-31. PubMed ID: 3141043
[TBL] [Abstract][Full Text] [Related]
16. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
[TBL] [Abstract][Full Text] [Related]
17. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.
Lunn RM; Langlois RG; Hsieh LL; Thompson CL; Bell DA
Cancer Res; 1999 Jun; 59(11):2557-61. PubMed ID: 10363972
[TBL] [Abstract][Full Text] [Related]
18. How does airway exposure of aflatoxin B1 affect serum albumin adduct concentrations? Evidence based on epidemiological study and animal experimentation.
Mo X; Lai H; Yang Y; Xiao J; He K; Liu C; Chen J; Lin Y
J Toxicol Sci; 2014 Aug; 39(4):645-53. PubMed ID: 25056789
[TBL] [Abstract][Full Text] [Related]
19. Detectable levels of serum aflatoxin B1-albumin adducts in the United Kingdom population: implications for aflatoxin-B1 exposure in the United Kingdom.
Turner PC; Dingley KH; Coxhead J; Russell S; Garner CR
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):441-7. PubMed ID: 9610795
[TBL] [Abstract][Full Text] [Related]
20. Restricted repair of aflatoxin B1 induced damage in alpha DNA of monkey cells.
Leadon SA; Zolan ME; Hanawalt PC
Nucleic Acids Res; 1983 Aug; 11(16):5675-89. PubMed ID: 6412212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
